8-K: XOMA Royalty Secures $125M in Equity Offerings
Capital Raise Announcement
XOMA Royalty Corporation has established two at-the-market equity offerings, totaling up to $125 million, for common and preferred stock to fund acquisitions and general corporate purposes.
Summary
- XOMA Royalty Corporation entered into a Common Stock Sales Agreement with Leerink Partners LLC to offer and sell up to $75,000,000 of its common stock.
- The company also entered into a Preferred Stock Sales Agreement with H.C. Wainwright & Co., LLC to offer and sell up to $50,000,000 of its depositary shares, each representing 1/1000th interest in 8.375% Series B Cumulative Perpetual Preferred Stock.
- Both offerings are 'at-the-market' (ATM) programs, allowing the company to sell shares from time to time on Nasdaq or other trading markets.
- The net proceeds from the common stock offering are intended for acquiring additional potential royalty and milestone revenue streams, working capital, and general corporate purposes.
- The net proceeds from the preferred stock offering are intended to fund future dividends, acquire additional potential royalty and milestone revenue streams, working capital, and general corporate purposes.
- Both sales agents, Leerink Partners and H.C. Wainwright, will receive a commission of up to 3.0% of the aggregate gross proceeds from the shares sold through them.
Sentiment
Score: 7
Explanation: The company has secured significant capital raising flexibility through two at-the-market offerings, which is positive for funding future growth and dividends. However, the potential for dilution from common stock sales introduces a moderate negative sentiment, balancing the overall outlook.
Positives
- Secured significant capital raising flexibility with up to $125 million available through ATM offerings.
- Intended use of proceeds for acquiring additional royalty and milestone revenue streams supports potential future growth.
- Preferred stock offering specifically earmarks funds for future dividends, which can be attractive to income-focused investors.
- ATM offerings provide a cost-effective and flexible method for capital raises compared to traditional underwritten offerings.
Negatives
- Potential for dilution of common shareholders due to the issuance of up to $75,000,000 in new common stock.
- Continuous sales under ATM programs can exert downward pressure on the stock price over time.
- The company has no obligation to sell, and the agents have no obligation to purchase, meaning the full amount may not be raised.
Risks
- Market conditions may materially impair the ability of the sales agents to sell the common or depositary shares.
- The sales agreements can be terminated by either party or by the agents under certain circumstances, including a material adverse change in the company's business or financial condition.
- The issuance of additional common stock will dilute the ownership interest of existing common shareholders.
- The company's ability to acquire additional royalty and milestone revenue streams is subject to market availability and successful negotiation.
Future Outlook
The company intends to use the net proceeds from these offerings to acquire additional potential royalty and milestone revenue streams, for working capital, and other general corporate purposes. Proceeds from the preferred stock offering will also be used to fund future dividends.
Management Comments
- Management intends to use the net proceeds from the common stock offering to acquire additional potential royalty and milestone revenue streams, for working capital, and other general corporate purposes.
- Management intends to use the net proceeds from the preferred stock offering to fund future dividends and any remaining net proceeds to acquire additional potential royalty and milestone revenue streams, for working capital, and other general corporate purposes.
Industry Context
At-the-market (ATM) offerings are a common and flexible capital-raising tool for publicly traded companies, particularly in sectors like biotechnology or royalty aggregation where strategic acquisitions are key to growth. This approach allows companies to tap into equity markets opportunistically, minimizing market impact compared to large, fixed-price offerings. For a royalty company like XOMA, securing capital for new royalty stream acquisitions is fundamental to its business model and growth strategy.
Comparison to Industry Standards
- ATM offerings are a standard capital-raising mechanism, widely used across various industries, including biotech and specialty finance, for their flexibility and lower upfront costs compared to traditional underwritten offerings.
- The commission rate of up to 3.0% for the sales agents is within the typical range for ATM programs, which commonly fall between 1% and 3% of gross proceeds.
- The dual offering structure (common and preferred stock) is a sophisticated capital management strategy, allowing the company to target different investor segments (growth-oriented for common, income-oriented for preferred) and optimize its capital structure.
- The stated use of proceeds for acquiring additional royalty and milestone revenue streams aligns directly with the core business strategy of a royalty corporation, similar to how other royalty companies (e.g., Royalty Pharma, HealthCare Royalty Partners) fund their growth.
Stakeholder Impact
- Shareholders (Common Stock): Face potential dilution as new common shares are issued, which could impact earnings per share and share price.
- Shareholders (Preferred Stock): New preferred shares may be issued, potentially affecting the trading dynamics or liquidity of existing preferred shares.
- Company: Gains enhanced financial flexibility and capital to pursue strategic acquisitions and manage liquidity, supporting long-term growth objectives.
- Creditors: A stronger capital base and improved liquidity from the capital raise could be viewed positively, potentially reducing credit risk.
Next Steps
- The company may offer and sell common stock and depositary shares from time to time through the appointed sales agents.
- Proceeds are intended to be used for acquiring additional potential royalty and milestone revenue streams.
- Proceeds from the preferred stock offering are intended to fund future dividends.
- Proceeds will also be used for working capital and other general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| 2024-03-08 | Registration Statement on Form S-3 (File No. 333-277794) originally filed with the SEC. |
| 2024-06-17 | Registration Statement on Form S-3 declared effective by the SEC. |
| 2025-10-03 | Common Stock Sales Agreement entered into with Leerink Partners LLC. |
| 2025-10-03 | Preferred Stock Sales Agreement entered into with H.C. Wainwright & Co., LLC. |
| 2025-10-03 | Prospectus supplements filed with the SEC in connection with the offerings. |
Recommendation
holdThe establishment of two at-the-market offerings provides XOMA Royalty Corporation with significant financial flexibility to pursue strategic acquisitions and fund future dividends. While this is a positive for long-term growth potential and capital management, the inherent dilution risk associated with common stock sales and the lack of immediate, specific growth catalysts warrant a 'hold' recommendation. Investors should monitor the deployment of capital and the impact on future revenue streams and profitability.
Keywords
XOMA Royalty, ATM offering, capital raise, equity offering, common stock, preferred stock, royalty streams, Nasdaq, Leerink Partners, H.C. Wainwright, corporate finance, dilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.